Article info
PDFHepatology
Original research
PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF
- Correspondence to Professor Jun Li, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University School of Medicine First Affiliated Hospital, Hangzhou, Zhejiang, China; lijun2009{at}zju.edu.cn; Professor Xin Chen; xinchen{at}zju.edu.cn; Professor Jonel Trebicka; jonel.trebicka{at}efclif.com; Professor Di Wang; diwang{at}zju.edu.cn
Citation
PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF
Publication history
- Received October 17, 2020
- Revised December 25, 2020
- Accepted December 26, 2020
- First published January 11, 2021.
Online issue publication
December 08, 2021
Article Versions
- Previous version (11 January 2021).
- Previous version (18 October 2021).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.